A2494512
cinnarizine , ＞98.0%(HPLC)(T) , 298-57-7
Synonym(s):
1-trans-Cinnamyl-4-diphenylmethylpiperazine;Cinnarizine
CAS NO.：298-57-7
Empirical Formula: C26H28N2
Molecular Weight: 368.51
MDL number: MFCD00056037
EINECS: 206-064-8
| Pack Size | Price | Stock | Quantity |
| 1G | RMB39.20 | In Stock |
|
| 10G | RMB239.20 | In Stock |
|
| 50g | RMB959.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 117-120°C |
| Boiling point: | 488.83°C (rough estimate) |
| Density | 1.1818 (rough estimate) |
| refractive index | 1.7620 (estimate) |
| storage temp. | Sealed in dry,2-8°C |
| solubility | Soluble in chloroform at 50mg/ml |
| pka | pKa 7.47(H2O t=25.0 ) (Uncertain) |
| form | powder |
| color | white |
| Water Solubility | 0.75g/L(temperature not stated) |
| Merck | 14,2305 |
| InChIKey | DERZBLKQOCDDDZ-JLHYYAGUSA-N |
| CAS DataBase Reference | 298-57-7(CAS DataBase Reference) |
| NIST Chemistry Reference | Cinnarizine(298-57-7) |
Description and Uses
For the treatment of vertigo/meniere's disease, nausea and vomiting, motion sickness and also useful for vestibular symptoms of other origins.
Safety
| Symbol(GHS) |    GHS07,GHS08,GHS09 |
| Signal word | Danger |
| Hazard statements | H315-H360-H410 |
| Precautionary statements | P273-P391-P501-P264-P280-P302+P352-P321-P332+P313-P362 |
| Hazard Codes | Xn |
| Risk Statements | 20/22-36/37/38-42/43 |
| Safety Statements | 22-24/25-36-26 |
| WGK Germany | 2 |
| RTECS | TL3430000 |
| HS Code | 2933.59.2100 |
| Toxicity | LD50 oral in rat: > 6500mg/kg |
